Bulk deal on February 19: Global banking and financial services major Goldman Sachs bought shares of the leading stock exchange BSE for ₹401 crore through an open market transaction on Wednesday, February 19, 2025.
According to bulk deal data on the National Stock Exchange (NSE), US-based Goldman Sachs, through its arm Goldman Sachs (Singapore), purchased 7.28 lakh shares of BSE. The shares of Mumbai-headquartered BSE were picked up at an average price of ₹5,504.42 apiece, taking the deal value to ₹401.19 crore.
Details of the sellers of BSE shares could not be ascertained on the bourse. On Wednesday, BSE shares rallied 8.14 per cent to close at ₹5,608.50 per piece on the NSE. On February 6, 2025, BSE reported its total net profit doubling to nearly ₹220 crore for the three-month period ending December 2024.
The leading stock exchange posted a net profit of ₹108.2 crore in the same quarter of the preceding fiscal. The exchange recorded its highest-ever quarterly revenue of ₹835.4 crore in the October-December period of the current financial year (FY25), a 94 per cent jump from ₹431.4 crore in the same period preceding fiscal. BSE witnessed an average daily turnover of ₹6,800 crore for the quarter under review compared to ₹6,643 crore a year ago.
BSE's average daily turnover was ₹6,800 crore for the quarter under review, compared to ₹6,643 crore a year ago. Its derivatives segment sustained its growth trajectory in the quarter with a daily premium turnover of ₹8,758 crore compared to ₹2,550 crore in the year-ago period.
“Throughout 2024, BSE demonstrated focus and resilience amidst challenges on the business and regulatory front by introducing new products and market enhancements and expanding our strategic footprint,” said Sundararaman Ramamurthy, Managing Director and Chief Executive Officer of BSE.
Domestic equity benchmarks Sensex and Nifty ended marginally lower in a volatile trade today, dragged by blue-chip IT stocks. The 30-share BSE benchmark Sensex dipped 28.21 points or 0.04 per cent to settle at 75,939.18. Intra-day, it hit a high of 76,338.58 and a low of 75,581.38, gyrating 757.2 points. The NSE Nifty skidded 12.40 points or 0.05 per cent to 22,932.90.
Gains in heavyweight financials countered losses in pharma and IT stocks on concerns that President Donald Trump would impose more tariffs on US imports. Trump said he intends to levy auto tariffs "in the neighbourhood of 25 per cent" and similar duties on semiconductors and pharmaceutical imports.
This resulted in Indian pharma stocks falling 0.7 per cent as the US accounts for nearly 31 per cent of total domestic pharma exports. IT stocks, which also get a significant chunk of their revenue from the US, lost 1.3 per cent on the day.
Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.